Can I read Guinazu - Evaluation of The Impact and Cost-Effectiveness of Respiratory Syncytial Virus Prev - ssrn-4754920 on EtoBox?

Guinazu - Evaluation of The Impact and Cost-Effectiveness of Respiratory Syncytial Virus Prev - ssrn-4754920 by caballeromauricio is a document available to read on EtoBox.

What is Guinazu - Evaluation of The Impact and Cost-Effectiveness of Respiratory Syncytial Virus Prev - ssrn-4754920 about?

This study evaluates the cost-effectiveness of RSV prevention strategies, specifically maternal vaccines and monoclonal antibodies, for infants in Argentina over a ten-year period. Both interventions could prevent at least 25% of RSV deaths in children under five, with a cost per DALY averted of approximately $5,285 for Nirsevimab and $5,335 for RSVpreF at a price of $50 per dose. The findings suggest that these interventions are worth considering if priced appropriately and that a seasonal immunization str

Author

caballeromauricio

Language

EN